Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Other Current Liabilities
Glenmark Life Sciences Ltd
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Other Current Liabilities
₹375.6m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Current Liabilities
₹55.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Other Current Liabilities
₹24.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Current Liabilities
₹77.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
13%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Other Current Liabilities
₹24.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Current Liabilities
₹9.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
5%
|
See Also
What is Glenmark Life Sciences Ltd's Other Current Liabilities?
Other Current Liabilities
375.6m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Current Liabilities amounts to 375.6m INR.
What is Glenmark Life Sciences Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-50%
Over the last year, the Other Current Liabilities growth was 0%. The average annual Other Current Liabilities growth rates for Glenmark Life Sciences Ltd have been -66% over the past three years , -50% over the past five years .